What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His primary areas of investigation include Breast cancer, Pathology, Molecular pathology, Cancer and Cancer research.
His Breast cancer study deals with the bigger picture of Internal medicine.
As part of the same scientific family, Jorge S. Reis-Filho usually focuses on Pathology, concentrating on Ductal carcinoma and intersecting with Hyperplasia.
His research in Molecular pathology intersects with topics in Gene expression profiling, Amplicon, Disease, Comparative genomic hybridization and Anatomical pathology.
His work in Cancer addresses subjects such as Genetic heterogeneity, which are connected to disciplines such as Genetic diversity.
His Cancer research study integrates concerns from other disciplines, such as Carcinogenesis, Chromogenic in situ hybridization, Targeted therapy and Epidermal growth factor receptor.
His most cited work include:
- Triple-negative breast cancer. (2186 citations)
- International network of cancer genome projects (1611 citations)
- The landscape of cancer genes and mutational processes in breast cancer (1263 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Breast cancer, Cancer research, Pathology, Cancer and Internal medicine.
His Breast cancer research is multidisciplinary, incorporating perspectives in Molecular pathology, Gene and Bioinformatics.
Jorge S. Reis-Filho works mostly in the field of Cancer research, limiting it down to concerns involving Mutation and, occasionally, Germline.
His Pathology study combines topics from a wide range of disciplines, such as Ductal carcinoma and Comparative genomic hybridization.
His Cancer research includes themes of Genetic heterogeneity, Germline mutation and Basal.
His study looks at the relationship between Internal medicine and fields such as Oncology, as well as how they intersect with chemical problems.
He most often published in these fields:
- Breast cancer (54.95%)
- Cancer research (42.17%)
- Pathology (39.15%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (42.17%)
- Breast cancer (54.95%)
- Cancer (26.24%)
In recent papers he was focusing on the following fields of study:
Jorge S. Reis-Filho focuses on Cancer research, Breast cancer, Cancer, Internal medicine and Oncology.
His Cancer research research integrates issues from Exome sequencing, Somatic cell, Carcinogenesis, Mutation and Gene.
The Breast cancer study which covers Genetic heterogeneity that intersects with CDKN2A.
His Cancer research includes elements of Transcriptome, Lung cancer and DNA sequencing.
His Oncology course of study focuses on Precision medicine and Translational research.
His Ductal carcinoma study frequently links to related topics such as Pathology.
Between 2017 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers. (223 citations)
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants. (154 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Jorge S. Reis-Filho spends much of his time researching Cancer research, Breast cancer, Internal medicine, Oncology and Cancer.
The various areas that Jorge S. Reis-Filho examines in his Cancer research study include Mutation, Transcription factor, Gene, Mutant and Estrogen receptor alpha.
His research in Breast cancer is mostly concerned with Estrogen receptor.
His work on Lapatinib, Trastuzumab, Survival analysis and Serous ovarian cancer is typically connected to Clinical Practice as part of general Internal medicine study, connecting several disciplines of science.
He interconnects Precision medicine, Clinical trial, Metastatic breast cancer and Intratumor heterogeneity in the investigation of issues within Oncology.
His Cancer research is multidisciplinary, relying on both Fusion gene and MEDLINE.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
